Global View of HIV Infection 2011
DOI: 10.5772/22995
|View full text |Cite
|
Sign up to set email alerts
|

Non-Tuberculous Mycobacteria in Uganda: A Problem or Not?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 40 publications
0
1
0
Order By: Relevance
“…Until recently, the focus has been on identifying known zoonotic mycobacteria such as M. bovis ; however, not much is known about the epidemiology and implications of the other potentially zoonotic mycobacteria including M. avium intracellulare complex and other NTM (Gcebe & Hlokwe, 2017). This is despite the growing evidence base of the role of NTM as true human pathogens in NTM pulmonary disease, their resistance to first‐ and second‐line anti‐TB drugs and the implications for the management of human TB cases (Cheng et al., 2017; Fedrizzi et al., 2017; Hoza et al., 2016; Kankya et al., 2011; Monde, Munyeme, Muwonge, Muma, & Malama, 2018; Muwonge et al, 2011; Nishiuchi et al., 2017; Wang et al., 2014). In addition to their growing pathogenic significance and drug resistance, environmental NTM compromise accurate diagnosis of TB in both humans and livestock, through the cross‐reactivity and the reduction in sensitivity of common diagnostic tests (Gcebe & Hlokwe, 2017; Jenkins et al., 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Until recently, the focus has been on identifying known zoonotic mycobacteria such as M. bovis ; however, not much is known about the epidemiology and implications of the other potentially zoonotic mycobacteria including M. avium intracellulare complex and other NTM (Gcebe & Hlokwe, 2017). This is despite the growing evidence base of the role of NTM as true human pathogens in NTM pulmonary disease, their resistance to first‐ and second‐line anti‐TB drugs and the implications for the management of human TB cases (Cheng et al., 2017; Fedrizzi et al., 2017; Hoza et al., 2016; Kankya et al., 2011; Monde, Munyeme, Muwonge, Muma, & Malama, 2018; Muwonge et al, 2011; Nishiuchi et al., 2017; Wang et al., 2014). In addition to their growing pathogenic significance and drug resistance, environmental NTM compromise accurate diagnosis of TB in both humans and livestock, through the cross‐reactivity and the reduction in sensitivity of common diagnostic tests (Gcebe & Hlokwe, 2017; Jenkins et al., 2018).…”
Section: Introductionmentioning
confidence: 99%